Key Points Sold 111,305 shares of ONEQ, an estimated $8.92 million trade based on quarterly average pricing Transaction ...
Wall Street expects Atlassian's adjusted earnings to increase at 19% annually through the fiscal year ending in June 2027.
U.S. stocks were still treading water in the Wednesday afternoon session, with the Nasdaq Composite and the S&P 500 gradually trimming their earlier gains. The Nasdaq Composite has been wavering ...
Nasdaq climbs midday as Microsoft-OpenAI deal fuels AI optimism. Tech leads gains while traders await the Fed’s rate forecast ...
Investor's Business Daily on MSN
Stock Market Today: Dow, S&P 500, Nasdaq Close At New Highs On Cool CPI Data
ShopifySHOP and Leaderboard stock Micron Technology MU were top gainers in the Nasdaq 100, while Ford Motor F and Coinbase ...
Tech stocks lift US stock market today as Nasdaq and S&P500 surge toward all-time highs. Apple hits record, investors await ...
U.S. stocks closed higher Friday as investors parsed the latest inflation data from the Fed's preferred gauge. All three ...
CNN Money Fear and Greed index eased, but stayed in 'Fear' zone on Thursday. Stocks rose on renewed sanctions on Russia, ...
Wall Street just can’t stay away from riskier stocks. After sliding on Wednesday, the Nasdaq Composite was back up 0.8%. The S&P 500 was up 0.5%. The Dow was up 83 points, or 0.2%.
Fintel on MSN
Ligand Pharmaceuticals Incorporated - Equity Right (LGNZZ) Price Target Decreased by 44.49% to 0.08
The average one-year price target for Ligand Pharmaceuticals Incorporated - Equity Right (OTCPK:LGNZZ) has been revised to $0.08 / share. This is a decrease of 44.49% from the prior estimate of $0.14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results